VYNE: VYNE Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Keep researching VYNE
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- VYNE insider tradesEvery buy and sale reported by VYNE Therapeutics Inc. officers, directors and large holders.
- VYNE dividend historyDividends VYNE Therapeutics Inc. has declared, with ex-dates and payment dates.
Quantisnow market dataNASDAQ
VYNE
VYNE Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for VYNE
Full VYNE profile on Quantisnow Follow VYNE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time